- Home
- PRTS vs IGC Comparison
PRTS vs IGC Comparison
Compare PRTS & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTS | IGC |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 31.2M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRTS | IGC |
|---|---|---|
| Price | $0.51 | $0.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $0.70 | ★ $4.13 |
| AVG Volume (30 Days) | ★ 1.4M | 975.0K |
| Earning Date | 11-10-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $560,632,000.00 | $1,106,000.00 |
| Revenue This Year | N/A | $3.54 |
| Revenue Next Year | N/A | $15.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.37 | $0.25 |
| 52 Week High | $1.42 | $0.50 |
Technical Indicators
Market Signals| Indicator | PRTS | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 46.99 |
| Support Level | $0.47 | $0.28 |
| Resistance Level | $0.59 | $0.31 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 58.61 | 36.24 |
Price Performance
Historical ComparisonAbout PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.